$JHX

James Hardie Industries plc. Stock 12‑Month Price Target Raised to $32.6, Implies 8% Upside

Analyst estimates cited by FactSet show James Hardie Industries plc. average 12-month price target increased to $32.6 from $32.37. Forecasts range from $24.91 to $40. Based on the Aug. 7 close, the target implies about 8% upside. Consensus remains “Buy” with 15 Buys, 8 Holds, and 0 Sells.

Original reporting
Published Aug 9, 2026, 11:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 3:06 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
James Hardie Industries plc. Stock 12‑Month Price Target Raised to $32.6, Implies 8% Upside — source image
Decision brief

The 30-second read

$JHXBullishLow
01

Why it matters

The update indicates slightly more bullish sell-side expectations (higher average target) while maintaining a “Buy” consensus, but it does not introduce new operational or financial information from the company.

02

Market read

Useful for sentiment tracking, but not a standalone fundamental catalyst.

03

What to watch

The article provides no thesis behind the target change, so traders should wait for the underlying analyst rationale or any company-specific news.

Relevance 4/10Novelty 4/10Timing: published late on 2026-08-09, for positioning ahead of the next trading session

Background

This is a short FactSet-sourced summary of analyst consensus price targets and rating distribution for James Hardie.

Company-level read

Ticker impact

$JHXBullishMedium confidence
Context

The article says James Hardie’s average analyst price target rose from $32.37 to $32.6, implying about 8% upside from the Aug. 7 close.

Expected impact

Likely mild upward bias for JHX sentiment, with limited follow-through unless additional analyst notes or company-specific catalysts emerge.

Evidence & confidence

The only new datapoint is the updated consensus target range and implied upside; no earnings, guidance, or company event is disclosed.

Market effects

Minimal sector read-through because the update is purely analyst-target related with no new industry or company fundamentals.

No specific regional impact described beyond general sentiment for the issuer.

No global macro or cross-border transaction details provided.

Counterpoint

Price-target changes can lag or reflect already-known expectations; without new fundamentals, the market may discount the update quickly.

Key entities

  • James Hardie Industries plc.

    Subject of the article; analyst consensus price target raised to $32.6 with implied ~8% upside from Aug. 7 close.

Related articles

$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

$JHXHighAI 9/10

James Hardie to sell Fermacell for €840m to Holcim

James Hardie will sell its European walling and flooring business, Fermacell, to Holcim for €840m. The company plans to close its European fibre cement business, focusing on North America. Proceeds will repay debt and fund a $250m share repurchase program. Holcim expects the deal to be earnings-accretive from 2027.

$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.

$JHXHighAI 9/10

James Hardie Selling European Fermacell Business for $980 Million to Holcim

James Hardie Industries is selling its European Fermacell business to Holcim for $980 million, aiming to focus on higher-growth markets. The deal, expected to close in early 2027, will strengthen James Hardie's balance sheet and reduce debt. The company plans to use $600 million of the proceeds to repay debt and authorized a $250 million share repurchase program.

$JHXHighAI 9/10

James Hardie Industries plc: James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million

James Hardie (JHX) is selling its European operations, including Fermacell, to Holcim (HOLN) for €840 million. The company will also close its European fiber cement business. Proceeds will be used to repay debt and fund a $250 million share buyback program. The deal is expected to close in early 2027.